This inventor holds 76 USPTO granted patents and 5 published patent applications, plus 8 CIPO patents and 30 EPO patents, primarily in Heteroaryl Compounds (CPC class A61K). Top assignees: Amgen Inc., Sunshine Lake Pharma Co., Ltd., Calitor Sciences, LLC. Active years: 2002-2021.
Inventors with similar research interests:
Location History:
- Thousand Oaks, CA (US) (2005 - 2015)
- Okemos, MI (US) (2002 - 2017)
- Newbury Park, CA (US) (2013 - 2021)
Company Filing History:
31 out of 2,067 
27 out of 119 
24 out of 24 
Years Active: 2002-2021
Areas of Expertise:
Title: Ning Xi: Innovator in Pharmaceutical Chemistry
Introduction
Ning Xi, based in Thousand Oaks, California, is a prolific inventor with a remarkable portfolio of 76 patents. His contributions to the field of pharmaceutical chemistry have led to significant advancements in the treatment of various diseases, showcasing his dedication and expertise as an innovator.
Latest Patents
Ning Xi's latest patents reflect his focus on developing novel therapeutic agents. One of his significant inventions is a patent for "Salts of pyrazolo[1,5-a]pyridine derivative and use thereof." This invention provides salts of pyrazolo[1,5-α]pyridine derivatives, which can be utilized in pharmaceutically acceptable compositions to prevent or treat proliferative disorders or pulmonary fibrosis.
Another noteworthy patent is titled "Substituted aminopyrimidine compounds and methods of use." This invention revolves around the preparation and applicability of new aminopyrimidine derivatives as drug candidates, either in their free form or as pharmaceutically acceptable salts. These compositions target disorders mediated by PI3K enzymes, aiming to treat conditions such as immunity and inflammation disorders, as well as hyperproliferative disorders like leukemias and solid tumors in mammals, particularly humans.
Career Highlights
Throughout his career, Ning has accumulated a wealth of experience, having worked with leading companies in the pharmaceutical industry. Notable among these are Amgen Inc. and Sunshine Lake Pharma Co., Ltd., where he has contributed his innovative insights into drug development and formulation.
Collaborations
In addition to his impressive patent portfolio, Ning Xi has collaborated with esteemed professionals in his field, including Shimin Xu and Tae-Seong Kim. These collaborations have fostered a research environment conducive to innovation, further enhancing the impact of his work on the pharmaceutical landscape.
Conclusion
Ning Xi's extensive patent portfolio and collaborative efforts highlight his significant contributions to pharmaceutical chemistry. His inventive spirit and dedication to addressing critical health issues through innovative drug development solidify his reputation as a leading inventor in the industry. As he continues to push the boundaries of research and development, the medical community eagerly anticipates the potential benefits of his future inventions.